Fabrizio Bellavia
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic
Papers
3
Total Citations
35
H-Index
3
About
Fabrizio Bellavia is a leading urologic surgeon and researcher at the forefront of robotic surgery innovation, with a primary focus on comparative robotic platforms and functional outcomes in prostate and bladder cancer treatment. His landmark work provides the first rigorous, propensity score-matched comparisons between the novel Hugo™ RAS system and the established daVinci platform for robot-assisted radical prostatectomy (RARP). In his 2024 study, which has already garnered 21 citations, Bellavia demonstrated that the Hugo™ system achieves perioperative outcomes comparable to the daVinci, offering a viable alternative in the rapidly expanding robotic surgery landscape. He extended this analysis with a one-year follow-up study, confirming equivalent oncological and functional results between the two platforms. Beyond prostate surgery, Bellavia has made important contributions to female sexual health after radical treatment for muscle-invasive bladder cancer (MIBC), authoring a 2025 systematic review that highlights this often-overlooked aspect of quality of life. His work is instrumental in guiding surgical decision-making, fostering competition in the robotic market, and ensuring that patient-centered outcomes remain central to technological adoption.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3